Functional Effectiveness of Removable Dentures in Patients with Dental Manifestations of Sensory Neuropathy Associated with Metabolic Disorders

Authors

DOI:

https://doi.org/10.33295/1992-576X-2025-6-100

Keywords:

sensory peripheral neuropathy, complications of orthopedic rehabilitation, partial removable prostheses, implantation planning, metabolic disorders, OHIP-14

Abstract

This study examines the specific dental manifestations of sensory peripheral neuropathy (SPN) and their impact on the parameters of stability, retention, and comfort when wearing dentures (DPN). It has been established that impaired sensory feedback due to neuropathy is a significant factor that reduces denture tolerance and increases the risk of functional dysfunction, especially in patients with poor metabolic control.
Objective: To identify manifestations of sensory peripheral neuropathy (SPN) in the oral cavity associated with metabolic disorders and to assess their impact on the functional efficiency of removable dentures in patients with type 2 diabetes mellitus (T2DM) and metabolic-associated steatosis of the liver (MASL).
Materials and methods: Forty-three patients aged 45–75 years with partial edentulism of Kennedy class I–II, who used dentures, were examined. The main group (A) consisted of patients with clinically confirmed MP and SPN: A1 — 16 patients with PD + T2DM + SPN; A2 — 15 patients with PD + MASL + SPN. The control group (B) included 12 patients with PD without diagnosed MP or SPN.
Objective examination methods: clinical examination, thermoreception analysis, discrimination sensitivity analysis, electro­myography.
Subjective examination methods: standardized OHIP-14 questionnaire (Oral Health Impact Profile; 14 questions, scale 0–4), and assessment of patient tolerance to the prosthesis using VAS (Visual Analog Scale; scale 0–10).
Results: The study showed that the manifestations of SPN in patients with T2DM and MASL had certain differences. In subgroup A1, SPN was manifested by temperature hyposensitivity and a high threshold of exteroception of the prosthetic bed (83% of patients), while in subgroup A2 it was manifested by glossodynia and temperature hypersensitivity (80%). In both subgroups, autonomic symptoms were observed: xerostomia (A1—92%, A2—60%), taste changes (A2—70%), which correlated with the degree of MP. In patients of group A, a significant reduction in the amplitude of biopotentials and asymmetry of the bioelectric activity of the masticatory muscles was observed compared to the control group. During chewing, significant differences in the magnitude and duration of chewing cycles and a decrease in the duration of rest periods were noted.
According to the OHIP-14 and VAS results, both subgroups of group A had significantly lower stability, retention, and comfort when wearing dentures compared to group B (foreign body sensation, insufficient control over dentures), despite objectively high-quality manufacturing. A strong inverse correlation was found between the threshold of mucosal pain sensitivity and subjective comfort when wearing dentures: the higher the threshold of sensitivity, the lower the tolerance (r = − 0.72, p < 0.01).
Conclusions: SPN associated with MP significantly impairs adaptation and reduces the functional efficiency of dentures, which negatively affects the quality of life and the success of orthopedic rehabilitation. Early diagnosis of SPN manifestations in the oral cavity may indicate IACS and T2DM and is key to effective treatment and dental prosthetics. The optimal option for such patients may be an orthopedic construction supported by implants, along with optimization of metabolic control and symptomatic therapy.

Downloads

Download data is not yet available.

Author Biographies

R. Symonenko, Bogomolets National Medical University, Kyiv, Ukraine

Candidate of Medical Sciences, Associate Professor, Department of Orthopedic Dentistry

V. Parii, Bogomolets National Medical University, Kyiv, Ukraine

Candidate of Medical Sciences, Associate Professor, Department of Orthopedic Dentistry

References

Buchynskyi, M., Kamyshna, I., Halabitska, I., Petakh, P., Kunduzova, O., Oksenych, V., & Kamyshnyi, O. (2025). Unlocking the gut-liver axis: microbial contributions to the pathogenesis of metabolic-associated fatty liver disease. Front Microbiol, 16:1577724. PMID: 40351307. DOI: https://doi.org/10.3389/fmicb.2025.1577724

Zhang, Z., et al. (2025). Association between periodontitis and mortality in participants with metabolic dysfunction-associated steatotic liver disease: results from NHANES. BMC Oral Health, 25, 659. DOI: https://doi.org/10.1186/s12903-025-05959-7

Pigeot, I., & Ahrens, W. (2025). Epidemiology of metabolic syndrome. Pflügers Archiv-European Journal of Physiology, 477(5), 669–680. DOI: https://doi.org/10.1007/s00424-024-03051-7

Riahi, S. M., Moamer, S., Namdari M., et al. (2018). Patterns of clustering of the metabolic syndrome components and its association with coronary heart disease in the Multi Ethnic Study of Atherosclerosis (MESA): A latent class analysis. Int J Cardiol, 271, 13–18. DOI: https://doi.org/10.1016/j.ijcard.2018.05.080

Salehinia, F., Abdi, H., Hadaegh, F., et al. (2018). Abdominal obesity phenotypes and incident diabetes over 12 years of follow-up: The Tehran Lipid and glucose study. Diabetes Res Clin Pract, 144, 17–24. DOI: https://doi.org/10.1016/j.diabres.2018.07.021

Ng, T. P., Feng, L., Nyunt, M. S., et al. (2016). Metabolic Syndrome and the Risk of Mild Cognitive Impairment and Progression to Dementia: Follow-up of the Singapore Longitudinal Ageing Study Cohort. JAMA Neurol, 73(4), 456–463. DOI: https://doi.org/10.1001/jamaneurol.2015.4899

Camus, J. P. (1966). Gout, diabetes, hyperlipemia: a metabolic trisyndrome. Rev Rhum Mal Osteoartic, 33(1), 10-4 (in French). PMID: 5910828.

Chubirko, K. I. (2017). The diagnostics and clinical pattern of nonalcoholic fatty liver disease in patients with pre-diabetes and type 2 diabetes and obesity. Wiad Lek, 70(2), 208–212. PMID: 28511161. [In Ukrainian].

Aller, R., De Luis, D. A., Izaola, O., Conde, R., Gonzalez Sagrado, M., Primo, D., et al. (2011). Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial. Eur Rev Med Pharmacol Sci, 15(9), 1090–5. PMID: 22013734

Chavez, M., Ramirez, A., Hernández-Vásquez, A., Comandé, D., & Azañedo, D. (2025). Impact of subgingival periodontal treatment on systemic markers of inflammation in patients with metabolic syndrome: a systematic review of randomized clinical trials. Front Oral Health, 5: 1465820. DOI: https://doi.org/10.3389/froh.2024.1465820. PMID: 39902081.

Vegda, H. S., Patel, B., Girdhar, G. A., Pathan, M. S. H., Ahmad, R., Haque, M., Sinha, S., & Kumar, S. (2024). Role of Nonalcoholic Fatty Liver Disease in Periodontitis: A Bidirectional Relationship. Cureus, 16(7): e63775. PMID: 39100036. DOI: https://doi.org/10.7759/cureus.63775

Lam, D. W., & LeRoith, D. (2019). Metabolic Syndrome. In: Feingold K.R., Anawalt B., Blackman M.R. et al., eds. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. PMID: 25905173. (Electronic resource.) URL: https://pubmed.ncbi. nlm.nih.gov/25905173/ (access date: 10.10.2023).

Ussar, S., Fujisaka, S., & Kahn, R. (2016). Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome. Mol Metab, 5(9),795–803. DOI: https://doi.org/10.1016/j.molmet.2016.07.004

Shine, B. K., Son, M., Moon, S. Y., Han, S. H. (2024). Metabolic Dysfunction-Associated Steatotic Liver Disease and the Risk of Chronic Periodontitis: A Nationwide Cohort Study. Nutrients, 17(1), 125. DOI: https://doi.org/10.3390/nu17010125

Blüher, M. (2016). Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance? Clin Sci (Lond), 130(18),1603–1614. DOI: https://doi.org/10.1042/CS20160005

Chen, T. H., Hsiao, H. P., Chiu, Y. W. et al. (2014). Maternal diabetes or hypertension and lifestyle factors may be associated with metabolic syndrome: a population-based study in Taiwan. Kaohsiung J Med Sci, 30(2), 86–93. DOI: https://doi.org/10.1016/j.kjms.2013.09.001

Schulze, M. B. (2019). Metabolic health in normal-weight and obese individuals. Diabetologia, 62(4), 558–566. DOI: https://doi.org/10.1007/s00125-018-4787-8

Nielsen, J. (2017). Systems Biology of Metabolism: A Driver for Developing Personalized and Precision Medicine. Cell Metab, 25(3), 572–579. DOI: https://doi.org/10.1016/j.cmet.2017.02.002

Lovric, A., Granér, M., Bjornson, E., et al. (2018). Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolome. Sci Rep, 8(1), 14200. DOI: https://doi.org/10.1038/s41598-018-31865-w

Liu, Z., Zhang, C., Lee S., et al. (2019). Pyruvate kinase L/R is a regulator of lipid metabolism and mitochondrial function. Metab Eng, 52, 263–272. DOI: https://doi.org/10.1016/j.ymben.2019.01.001

Published

2026-01-30

How to Cite

Symonenko Р. В., & Parii В. В. (2026). Functional Effectiveness of Removable Dentures in Patients with Dental Manifestations of Sensory Neuropathy Associated with Metabolic Disorders. Actual Dentistry, (6), 100–107. https://doi.org/10.33295/1992-576X-2025-6-100

Issue

Section

PROSTHODONTICS

Most read articles by the same author(s)